Business Wire

BearingPoint study: Powered by the people! Successful organizations are built on a resilient workforce

21.7.2022 09:03:00 EEST | Business Wire | Press release

Share

Management and technology consultancy BearingPoint has created a deep-dive study on enabling people to manage and embrace change to drive organizational success. “Powered by the people,” the second of five companion pieces to the 2021 “Can you thrive under pressure study, analyzed over 5,000 projects to rank 150 leading resilient organizations. BearingPoint has also created a resilience benchmarking tool that enables any organization to assess its alignment with the five fundamental pillars of resilience.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220720005745/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

BearingPoint study: Successful organizations are built on a resilient workforce. (Graphic: Business Wire)

BearingPoint’s proprietary benchmarking tool shows that most organizations understand that success is based on empowering their people for change. Yet only 60% of organizations considered their people to be fully resilient. However, the study also concludes that even these organizations cannot afford to be complacent.

BearingPoint’s study found that an organization’s people-related strategy is vital to its overall success. Many organizations recognize that they can do more to create an environment for their people to be successful. For example, there is a clear correlation between manager autonomy and the success of transformation projects. Yet frontline manager autonomy is still low (22% in France, 19% in Germany and 30% in the United Kingdom), with communication cited as a key gap. 55% want more information during a project, 45% want clearer guidelines and desire to collaborate more, and 39% want access to specific expertise while implementing change projects. The study shows that best practice links your people to a clear purpose and vision, providing agile working models with the flexibility to respond and structured around multi-skilled teams empowered to make decisions.

BearingPoint’s research proves that an organization’s people strategy can only be successful if it is underpinned by the five dimensions of a resilient organization:

  • Empower people for change: Resilient companies support their people to adapt to change and uncertainty rapidly.
  • Understand the customer ecosystem: Resilient companies enable their people to understand their customers and supply chain; and they make sure their people interact positively with customers, suppliers and other stakeholders.
  • Align data centricity with business outcomes: People interconnected to data and data owned by the people ought to be an integral part of understanding the role of data in supporting business decisions.
  • Use technology to improve agility: Resilient companies use technology to enable people to be productive and involved.
  • Build effective governance for smart decisions: Resilient companies introduce people governance for better decision-making with appropriate structures, clear decision-making processes and effective escalations.

Andrew Montgomery, Global Leader Government and Public Sector at BearingPoint, notes: “Our insights support the view that organizations which have been the most successful in retaining, developing and managing their workforce during and post-pandemic are those that have recognized the importance of resilience as a core characteristic in its people. Their workforce strategies include specific outcomes related to creating an environment where people can develop, be supported and be empowered to become more resilient. And the indicators are that investment in these areas can lead to tangible results in terms of retention, employee wellbeing and performance.”

All the categories of organizations that BearingPoint studied showed that empowering their people for change was a key element of their strategy. However, people strategies lagged behind customer strategies. There were also variations across sectors, with government organizations having lower people resilience scores than other sectors. According to the study, leading private sector companies have responded to reoccurring crises by investing more in their people and therefore have benefited from increased company resilience.

Claudia Carr, Partner at BearingPoint, says: “There are many factors which support the development of resilience within your workforce. It starts with culture and is enhanced through learning and collaboration. Resilient organizations recognize the importance of soft skills, starting from hiring and as part of continuous development programs. The ability to manage change, communicate, collaborate and problem solve are all critical skills when navigating change. We see resilient organizations as those supporting the development of these skills, not only with their leaders but throughout the organization.”

About the study

BearingPoint analyzed over 5,000 client projects, built a model to assess how organizations create successful long-term transformations, and then calibrated resilience profiles based on five observed characteristics.

To find out more, you can download the study here: https://www.bearingpoint.com/en/insights-events/insights/successful-organisations-are-built-on-a-resilient-workforce/

About BearingPoint

BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: Consulting, Products, and Capital. Consulting covers the advisory business with a clear focus on selected business areas. Products provides IP-driven digital assets and managed services for business-critical processes. Capital delivers M&A and transaction services.

BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 13,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.

For more information, please visit:

Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press contact
Alexander Bock
Global Manager Communications
Telephone: +49 89 540338029
E-Mail: alexander.bock@bearingpoint.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release

OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye